These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15304558)

  • 21. A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor.
    Heitman LH; Göblyös A; Zweemer AM; Bakker R; Mulder-Krieger T; van Veldhoven JP; de Vries H; Brussee J; Ijzerman AP
    J Med Chem; 2009 Feb; 52(4):926-31. PubMed ID: 19161279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the binding of [3H]CGP54626 to GABAB receptors in the male bullfrog (Rana catesbeiana).
    Asay MJ; Boyd SK
    Brain Res; 2006 Jun; 1094(1):76-85. PubMed ID: 16725130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists.
    Zhu BT
    Biomed Pharmacother; 2005 Apr; 59(3):76-89. PubMed ID: 15795100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
    May LT; Lin Y; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric modulation of ligand-gated ion channels.
    Hogg RC; Buisson B; Bertrand D
    Biochem Pharmacol; 2005 Nov; 70(9):1267-76. PubMed ID: 16043127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.
    Kenakin T
    Trends Pharmacol Sci; 2007 Aug; 28(8):407-15. PubMed ID: 17629960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of negative allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2009 Jan; 14(1-2):41-9. PubMed ID: 18973826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allosteric regulation of receptors. I. Cooperative interaction and functional regulation].
    Balashov AM; Panchenko LF
    Biomed Khim; 2003; 49(6):517-41. PubMed ID: 16119081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative action of receptor mosaics: relevance of receptor topology and allosteric modulators.
    Francesco AL; Diego G; Susanna G; Giuseppina L; Amina WS; Sergi F; Rafael F; Kjell F
    J Recept Signal Transduct Res; 2008; 28(6):543-65. PubMed ID: 19096975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
    Fraley ME
    Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain.
    Childers SR; Li X; Xiao R; Eisenach JC
    J Neurochem; 2005 May; 93(3):715-23. PubMed ID: 15836630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights in insurmountable antagonism.
    Vauquelin G; Van Liefde I; Birzbier BB; Vanderheyden PM
    Fundam Clin Pharmacol; 2002 Aug; 16(4):263-72. PubMed ID: 12570014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.
    Rowe BA; Schaffhauser H; Morales S; Lubbers LS; Bonnefous C; Kamenecka TM; McQuiston J; Daggett LP
    J Pharmacol Exp Ther; 2008 Jul; 326(1):240-51. PubMed ID: 18430863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G protein-coupled receptors: a count of 1001 conformations.
    Vauquelin G; Van Liefde I
    Fundam Clin Pharmacol; 2005 Feb; 19(1):45-56. PubMed ID: 15660959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes.
    Mannoury la Cour C; Herbelles C; Pasteau V; de Nanteuil G; Millan MJ
    J Neurochem; 2008 Apr; 105(2):308-23. PubMed ID: 18021295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
    Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
    J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists.
    Sullivan SK; Brown MS; Gao Y; Loweth CJ; Lio FM; Crowe PD; Struthers RS; Betz SF
    Biochemistry; 2006 Dec; 45(51):15327-37. PubMed ID: 17176055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
    Heitman LH; Ye K; Oosterom J; Ijzerman AP
    Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.